CULTURE, DEVICE, AND COMPOSITION FOR PRODUCING ADULT OLIGODENDROCYTE-TYPE 2 ASTROCYTE PROGENITOR CELLS AND PROLIFERATING OLIGODENDROCYTE-TYPE 2 ASTROCYTE PROGENITOR CELLS
20190117704 ยท 2019-04-25
Assignee
Inventors
Cpc classification
A61K35/30
HUMAN NECESSITIES
C12N2501/385
CHEMISTRY; METALLURGY
C12N5/0622
CHEMISTRY; METALLURGY
C12M3/00
CHEMISTRY; METALLURGY
C12N5/0037
CHEMISTRY; METALLURGY
International classification
A61K35/30
HUMAN NECESSITIES
C12M3/00
CHEMISTRY; METALLURGY
C12M1/34
CHEMISTRY; METALLURGY
Abstract
The present invention provides a method for producing adult oligodendrocyte progenitor cells from proliferative oligodendrocyte progenitor cells, and a pharmaceutical composition having for an active ingredient thereof adult OPC produced according to that method. The method for producing adult OPC of the present invention is characterized by inducing proliferating OPC to differentiate into adult OPC by culturing in the presence of a ligand of a thyroid hormone receptor or retinoic acid receptor in a low oxygen environment. The present invention further provides adult OPC produced according to the production method of the present invention, and a pharmaceutical composition having these adult OPC as an active ingredient thereof.
Claims
1. A culture comprising: a serum-free medium not containing a thyroid hormone; and proliferating OPC.
2. The culture according to claim 1, wherein the proliferating OPC are a primary culture or a sub-culture of OPC collected from an organism.
3. A device for producing adult OPC, comprising: a composition comprising proliferating OPC and a serum-free medium; and an oxygen concentration controller.
4. A device for producing proliferating OPC, comprising: a composition comprising proliferating OPC and a serum-free medium not containing a thyroid hormone; and an oxygen concentration controller.
5. The device for producing adult OPC according to claim 3, the composition further comprising a ligand of a thyroid hormone receptor or retinoic acid receptor selected from the group consisting of 3,5,3,5-tetraiodo-L-thyronine (T4), 3,5,3-triiodo-L-thyronine (T3), a tetrazole compound having a structure similar to T4 or T3 and being able to bind to the thyroid hormone receptor, retinoic acid, and vitamin A.
6. The device for producing proliferating OPC according to claim 4, the composition further comprising a ligand of a thyroid hormone receptor or retinoic acid receptor selected from the group consisting of T4, T3, a tetrazole compound having a structure similar to T4 or T3 and being able to bind to the thyroid hormone receptor, retinoic acid, and vitamin A.
7. The device for producing adult OPC according to claim 3, wherein the proliferating OPC are cells obtained by primary culturing or sub-culturing OPC harvested from a living body.
8. The device for producing proliferating OPC according to claim 4, wherein the proliferating OPC are cells obtained by primary culturing or sub-culturing OPC harvested from a living body.
9. A composition comprising: a ligand of a thyroid hormone receptor or retinoic acid receptor selected from the group consisting of T4, T3, a tetrazole compound having a structure similar to T4 or T3 and being able to bind to the thyroid hormone receptor, retinoic acid, and vitamin A; adult OPC; a serum-free medium; and a gas of a low oxygen concentration.
10. The composition according to claim 9, wherein the oxygen concentration of the gas of a low oxygen concentration is in the range of 0.5 to 1.5% by volume.
11. A device for producing adult OPC, comprising: adult OPC; a ligand of a thyroid hormone receptor or retinoic acid receptor selected from the group consisting of T4, T3, a tetrazole compound having a structure similar to T4 or T3 and being able to bind to the thyroid hormone receptor, retinoic acid, and vitamin A; a serum-free medium; and an oxygen concentration controller.
12. The device for producing adult OPC according to claim 11, wherein the oxygen concentration controller can maintain the oxygen concentration in the range of 0.5 to 1.5% by volume, or in the range of 2.0 to 20.0% by volume, and switch the concentration from one to the other when required.
Description
BRIEF DESCRIPTION OF THE DRAWINGS
[0025]
[0026]
[0027]
[0028]
[0029]
[0030]
[0031]
[0032]
[0033]
[0034]
BEST MODE FOR CARRYING OUT THE INVENTION
[0035] The method for producing adult OPC according to the present invention (to also be referred to as the adult OPC production method according to the present invention) is characterized by having a step for inducing proliferating OPC to differentiate into adult OPC by culturing in the presence of a ligand of a thyroid hormone receptor or retinoic acid receptor in a low oxygen environment. As is disclosed in Non-Patent Document 2 and Non-Patent Document 3, thyroid hormone and retinoic acid are known to be factors that induce differentiation from OPC to oligodendrocytes in an environment having an oxygen concentration of 20% by volume. These factors were found for the first time by the inventors of the present invention to not function as differentiation induction factors in a low oxygen environment, but rather function as factors that induce differentiation to adult OPC in a dormant state, or in other words, induce proliferating OPC to differentiate into adult OPC by stimulating with a thyroid hormone receptor or retinoic acid receptor together with a hypoxic stimulus.
[0036] The proliferating OPC used in the adult OPC production method according to the present invention are OPC that actively undergo repeated cell division observed during organogenesis and soon after birth, and refer to cells having a cell cycle of 50 hours or less. The proliferating OPC used in the present invention may be proliferating OPC per se harvested from a living organism during organogenesis or soon after birth, or may be cells that have been allowed to proliferate by primary culturing or sub-culturing of proliferating OPC harvested from a living body. In addition, proliferating OPC differentiated from embryonic stem (ES) cells or induced pluripotent stem (iPS) cells can also be used in the present invention.
[0037] Harvesting of proliferating OPC from a living body and the subsequent culturing thereof can be carried out in accordance with ordinary methods. Proliferating OPC can be harvested in large numbers from the optic nerve in particular. For example, proliferating OPC can be harvested by excising the optic nerve of a rat soon after birth (1 to 10 days after birth) and slicing into sections, preparing a single cell suspension from the resulting sections, and isolating proliferating OPC from the single cell suspension by an immunological technique using antibody such as A2B5 antibody that recognizes molecules specifically expressed on the surface of OPC. There are no particular limitations on the medium used to culture the isolated proliferating OPC provided it is a medium that allows the proliferating OPC to be cultured without inducing differentiation. For example, proliferating OPC can be cultured in serum-free modified B-S medium or serum-free modified DMEM medium. At that time, an additive such as insulin, forskolin, PDGF-AA or neurotrophin-3 (NT-3) is preferably added to the medium. Proliferating OPC can be allowed to proliferate particularly efficiently by stimulating with PDGF-AA. Culturing at this time may be carried out at a standard oxygen concentration (roughly 20% by volume), may be carried out at the oxygen concentration in a living body (equivalent to an oxygen concentration of about 0.5% by volume to 8% by volume in the brain, although varying according to the particular tissue), or may be carried out at a low oxygen concentration (1.5% by volume or less).
[0038] In the adult OPC production method according to the present invention, the oxygen concentration of the gas used during culturing in order to induce differentiation of proliferating OPC into adult OPC is a concentration that is low enough to allow hypoxic stimulation of the proliferating OPC used. The upper limit value of oxygen concentration able to impart a hypoxic stimulus varies somewhat according to the tissue and species serving as the origin of those cells. The upper limit value of oxygen concentration that imparts a hypoxic stimulus to the proliferating OPC used can be determined experimentally as shown, for example, in Example 6 to be subsequently described. In the present invention, the oxygen concentration when culturing proliferating OPC in order to induce differentiation into adult OPC is preferably that of an environment having an oxygen concentration of 1.5% by volume or less, more preferably an environment having an oxygen concentration of 0.5% by volume to 1.5% by volume, even more preferably an environment having an oxygen concentration of 0.5% by volume to 1.2% by volume, and still more preferably an environment having an oxygen concentration of 0.5% by volume to 1.0% by volume. As described in a report by Kitamoto, et al. (Kitamoto, et al., Oncogene, 2013, Vol. 32, p. 4614-4621), a report by Sekiguchi, et al. (Sekiguchi, et al. , Journal of Cellular and Molecular Medicine, 2012, Vol. 16 (8), p. 1934-1945), and a report by Allen, et al. (Allen, et al., Tissue Engineering, 2006, Vol. 12 (11), p. 3135-3147), hypoxic stimuli can be imparted to cells derived from various species of living organisms such as humans, rats or mice by adjusting oxygen concentration to 1% by volume or less. Examples of an oxygen concentration controller include an oxygen potentiometer used in a cell culturing system comprising a low oxygen chamber and capable of adjusting the oxygen pressure to 1-140 mmHg or 0.1-20 vol. %. It is practically difficult to set the lower limit of the oxygen concentration in the culturing system to 0 mmHg or 0 vol. % by the oxygen concentration controller, because the media used for culturing usually contain an oxygen. Addition of an agent, such as 5% of sodium sulfite, to the medium would be required to completely remove the oxygen from the culturing system; however, such an addition is detrimental to the cultured cells. The upper limit of the oxygen concentration is 140 mmHg or 20 vol. %. The oxygen concentration in the air is about 21 vol. %. However, the culturing system usually contain 5% of CO.sub.2 to equilibrate the pH of the media containing sodium bicarbonate to around 7.2, the oxygen concentration in the culturing system is about 140 mmHg or 20 vol. %. Therefore, the lower limit is 1 mmHg or 0.1 vol. % and the upper limit is 140 mmHg or 20 vol. %. Here, the cell culturing system is not limited to one with the chamber or incubator for laboratory use. It includes a low oxygen incubation kit without a chamber etc., which can be commercially traded. For example, a commercially tradable small system for cell culturing comprising a pouch into which a medium for inducing differentiation of the adult OPC is added can be used. By using such a system and a gas concentration adjusting agent and measuring the O.sub.2 concentration with a pressure gauge, a low oxygen concentration environment is created and maintained by sealing. The oxygen concentration, when not inducing differentiation of proliferating OPC into adult OPC, is in the range of 2.0 to 20.0% by volume. The system used for performing the method of the present invention, for example, a device for producing adult OPC, may comprise an oxygen concentration controller that can maintain the oxygen concentration in the range of 0.5 to 1.5% by volume, or in the range of 2.0 to 20.0% by volume and switch the concentration from one to the other when required.
[0039] In the adult OPC production method according to the present invention, although there are no particular limitations on the gas composition other than the oxygen concentration of the gas during culturing in order to induce proliferating OPC to differentiate into adult OPC, the main component of the gas other than oxygen is preferably nitrogen, and the gas may also contain carbon dioxide. In the case of containing carbon dioxide, carbon dioxide concentration is preferably about 3% by volume to 10% by volume.
[0040] In the adult OPC production method according to the present invention, proliferating OPC are specifically cultured in a medium to which has been added a ligand of a thyroid hormone receptor or retinoic acid receptor in a gas having a low oxygen concentration. Examples of such media include medium obtained by adding a ligand of a thyroid hormone receptor or retinoic acid receptor to a medium such as serum-free modified B-S medium or serum-free modified DMEM medium that allows proliferating OPC to proliferate without inducing differentiation.
[0041] Examples of ligands of thyroid hormone receptors used in the present invention include 3,5,3,5-tetraiodo-L-thyronine (T4, also referred to as thyroxine) and 3,5,3-triiodo-L-thyronine (T3). In addition, tetrazole compounds that have a structure that resembles T3 or T4 and are capable of binding with thyroid hormone receptors may also be used. Examples of ligands of retinoic acid receptors used in the present invention include retinoic acid and vitamin A. The ligand used in the present invention is preferably T4, T3 or all-trans retinoic acid.
[0042] Proliferating OPC cells may be cultured in medium containing only one type of ligand or may be cultured in medium containing two or more types of ligands. In addition, the medium may contain both a ligand of a thyroid hormone receptor and a ligand of a retinoic acid receptor. More specifically, the medium may be a medium that contains one of either T3 or T4, a medium that contains both T3 and T4, or a medium that contains at least one of T3 and T4 and retinoic acid.
[0043] Although adult OPC obtained according to the adult OPC production method according to the present invention are in a dormant state in which proliferation has ceased, they retain bipotency and the ability to re-proliferate. Consequently, the resulting adult OPC are induced to undergo re-division and differentiation by a suitable stimulus in the same manner as adult OPC present in a living body. For example, the adult OPC undergo re-division as a result of being stimulated with PDGF, neuregulin (NRG) and a phosphodiesterase 1 inhibitor in the form of 1-methyl-3-(2-methylpropyl)xanthine (IBMX). On the other hand, these adult OPC differentiate to oligodendrocytes as a result of stimulating with TH and withdrawal of PDGF in an environment having an oxygen concentration of 20%.
[0044] According to the adult OPC production method according to the present invention, comparatively homogeneous adult OPC can be supplied more stably and in larger numbers than in the prior art. Consequently, the use of the resulting adult OPC as model cells and the like can be expected to dramatically accelerate the pace of research on the functions of adult OPC.
[0045] Myelin sheath can be expected to be repaired by the transmigration of adult OPC to sites of myelin sheath damage, demyelination sites or hypomyelination sites. In addition, differing from proliferating OPC, since adult OPC are in a dormant state while retaining the ability to differentiate, they offer the advantage of a lower risk of malignant transformation.
[0046] Consequently, adult OPC obtained according to the adult OPC production method according to the present invention can be used as an active ingredient of a pharmaceutical composition. This pharmaceutical composition is preferably used to treat hypomyelination, demyelination or myelin sheath damage. More specifically, these adult OPC can be expected to serve as active ingredients of pharmaceutical compositions used to treat and prevent, for example, trauma, amyotrophic lateral sclerosis (ALS), Parkinson's disease, multiple sclerosis (MS), progressive multifocal leukoencephalopathy (PML), encephalomyelitis (EPL), central pontine myelinolysis (CPM), Wallerian degeneration, adrenoleukodystrophy, Alexander disease, Pelizaeus-Merzbacher disease (PMD) or macular hole.
[0047] The adult OPC obtained according to the adult OPC production method according to the present invention can also be used to screen for substances having the ability to induce proliferation or induce differentiation of adult OPC. For example, screening of candidate substances can be carried out by carrying out a detection step, in which adult OPC are cultured in a medium containing the candidate substance for the ability to induce proliferation or induce differentiation, and measuring whether or not the adult OPC undergo re-division, or in other words, whether or not the number of adult OPC in the medium is increased by culturing, or detecting whether the adult OPC differentiate into oligodendrocytes, or in other words, whether antigen specific to differentiated cells is expressed in cells in the medium; and then respectively evaluating the candidate substance as having the ability to induce proliferation or induce differentiation in the adult OPC in the case the adult OPC have proliferated significantly or in the case cells are detected that have been induced to differentiate from the adult OPC. Confirmation of a difference in uptake of bromodeoxyuridine (BrdU) or confirmation of expression of a proliferation marker in the form of Ki-67 protein can be used as means for confirming the ability to induce proliferation. In the case the adult OPC undergoes re-division and the number of adult OPC increases significantly in the medium (two-fold or more and preferably ten-fold or more), the candidate substance added to the medium can be evaluated as having the ability to induce proliferation of adult OPC. In addition, in the case the adult OPC have differentiated into oligodendrocytes and antigen specific to differentiated cells is detected in cells in the medium, the candidate substance added to the medium can be evaluated as having the ability to induce differentiation of adult OPC. Examples of antigens specific to differentiated cells include proteolipid protein (PLP), 2,3-cyclic-nucleotide 3-phosphodiesterase (CNPase) and myelin basic protein (MBP).
EXAMPLES
[0048] Although the following provides a more detailed explanation of the present invention through examples thereof, the present invention is not limited by these examples. In addition, all of the animal experiment protocols indicated below were approved by the ethics committee of Keio University.
[0049] In addition, unless specifically indicated otherwise, the proliferating OPC used in the following examples were isolated from the optic nerves of 7-day-old rats (P7) in accordance with the immunopanning method of Barres, et al. (Barres, et al., Cell, 1992, Vol. 70, p. 31-46), and the purity thereof (percentage of proliferating OPC relative to all cells) was 99.9% or more.
Example 1
[0050] Proliferating OPC were cultured in medium containing thyroid hormone or medium not containing thyroid hormone in an environment having an oxygen concentration of 1.5% by volume followed by investigating the effect of thyroid hormone on the proliferation ability of the proliferating OPC.
[0051] 1000 proliferating OPC per flask were seeded into T25 culture flasks coated with poly-D-lysine (PDL) followed by culturing for 15 days each at 37 C. in a gas having an oxygen concentration of 1.5% by volume and carbon dioxide concentration of 5% by volume in TH-containing medium to which was added a thyroid hormone mixture (mixture consisting of equal parts of T3 and T4 (40 ng/mL), abbreviated as TH) or TH-free medium not containing TH. Serum-free modified B-S medium to which was added PDGF-AA (10 ng/mL), NT-3 (5 ng/mL), insulin (5 g/mL) and forskolin (5 M) was used for the TH-free medium, while medium obtained by adding TH (T3 and T4: 40 ng/mL each) to TH-free medium was used for the TH-containing medium.
[0052] The results of counting the numbers of cells in each flask are shown in Table 1, while the results of calculating the cell proliferation rates (multiples) are shown in
TABLE-US-00001 TABLE 1 Number of Cells Duration of Absence of thyroid Presence of thyroid culturing (days) hormone hormone 0 1,000 1,000 4 50,000 45,000 15 660,000 44,000
Example 2
[0053] Proliferating OPC were cultured in medium to which was added thyroid hormone in an environment having an oxygen concentration of 1.5% by volume or 20% by volume followed by investigating the effect of thyroid hormone on the differentiation ability of the proliferating OPC.
[0054] 300 proliferating OPC per culture dish were seeded into glass bottom culture dishes having a diameter of 12 mm and coated with PDL to prepare six culture dishes followed by culturing for 12 days at 37 C. in the TH-containing medium used in Example 1. Among the six culture dishes, three were cultured in a gas having an oxygen concentration of 1.5% by volume and carbon dioxide concentration of 5% by volume, while the remaining three culture dishes were cultured in a gas having an oxygen concentration of 20% by volume and carbon dioxide concentration of 5% by volume.
[0055] Following completion of culturing, the cells in each culture dish were fixed by treating for 5 minutes at room temperature in a 2.0% paraformaldehyde solution. Following primary immunostaining of the fixed cells using mouse anti-galactocerebroside (GC) antibody (provided by Martin C. Raff) and mouse A2B5 antibody (provided by Martin C. Raff), the cells were subjected to secondary staining with AlexaFluor 488-labeled mouse IgG antibody and AlexaFluor 568-labeled mouse IgM antibody (both available from Invitrogen Corp.) and then further stained with DAPI (Dojindo Laboratories Co., Ltd.). A2B5 antibody an antibody that is specific for OPC, while GC is an oligodendrocyte marker.
[0056]
[0057] On the basis of the above, when considering together with the results of Example 1, in the case of having cultured proliferating OPC in medium containing thyroid hormone in an environment having a low oxygen concentration, although the cells proliferated until a certain time, proliferation subsequently ceased, thereby making it possible to confirm these cells to be adult OPC for which differentiation into oligodendrocytes had been inhibited.
Example 3
[0058] Proliferating OPC were cultured in medium to which was added thyroid hormone or medium to which was added retinoic acid in an environment having an oxygen concentration of 1.5% by volume followed by investigating the effect of retinoic acid (RA) on the proliferating OPC.
[0059] Six glass bottom culture dishes having a diameter of 12 mm and coated with PDL were prepared by seeding with 300 proliferating OPC per culture disk, followed by culturing for 12 days at 37 C. in an environment having an oxygen concentration of 1.5% by volume and carbon dioxide concentration of 5% by volume. Three of the six culture dishes were cultured in the TH-containing medium used in Example 1, while the remaining three culture dishes were cultured in medium containing RA (medium obtained by adding all-trans retinoic acid (Sigma Corp., 1 ng/mL) to the TH-free medium used in Example 1).
[0060] Following completion of culturing, the numbers of cells that formed colonies were respectively counted and the number of cell divisions was determined for each colony.
[0061] In addition,
Example 4
[0062] An investigation was made as to whether or not adult OPC, obtained by hypoxic stimulation and TH-stimulation of proliferating OPC, have the ability to differentiate.
[0063] Six glass bottom culture dishes having a diameter of 12 mm and coated with PDL were prepared by seeding with 300 proliferating OPC per culture dish, followed by culturing for 15 days at 37 C. in the TH-containing medium used in Example 1 in an environment having an oxygen concentration of 1.5% by volume and carbon dioxide concentration of 5% by volume. Next, the medium of three of the six culture dishes were replaced with PDGF-free TH-containing medium (medium obtained by excluding PDGF from the TH-containing medium used in Example 1) followed by culturing for 5 days at 37 C. in a gas having an oxygen concentration of 1.5% by volume and carbon dioxide concentration of 5% by volume. The medium of the remaining three culture dishes was replaced with FBS-containing medium (serum-free modified B-S medium containing FBS (10%)) followed by culturing for 5 days at 37 C. in a gas having an oxygen concentration of 1.5% by volume and carbon dioxide concentration of 5% by volume.
[0064] Following completion of culturing, the cells in each culture dish were fixed by treating for 5 minutes at room temperature with a 2.0% paraformaldehyde solution followed by carrying out cell membrane permeation treatment. Following completion of cell membrane permeation treatment, the cells in one of the three culture dishes cultured with PDGF-free TH-containing medium and one of the three culture dishes cultured with FBS-containing medium were subjected to primary immunostaining using rat anti-MBP antibody (MAB386, Millipore Corp.) followed by subjecting to secondary staining using AlexaFluor 488-labeled mouse IgG antibody. Similarly, one of the three culture dishes cultured with PDGF-free TH-containing medium and one of the three culture dishes cultured with FBS-containing medium were subjected to primary immunostaining using mouse anti-CNPase antibody (C5922, Sigma Corp.) followed by subjecting to secondary staining using AlexaFluor 488-labeled mouse IgG antibody. After carrying out primary immunostaining on one of the three cultured dishes cultured with PDGF-free TH-containing medium and one of the three culture dishes cultured with FBS-containing medium using rabbit anti-GFAP antibody (G4546, Sigma Corp.), secondary staining was carried out using AlexaFluor 488-labeled anti-rabbit IgG antibody. 2,3-cyclic-nucleotide 3-phosphodiesterase (CNPase) and myelin basic protein (MBP) are oligodendrocyte markers, while glial fibrillary acidic protein (GFAP) is an astrocyte marker.
[0065]
Example 5
[0066] An investigation was made of the ability of adult OPC, obtained by subjecting proliferating OPC to hypoxic stimulation and TH stimulation, to re-proliferate and differentiate.
[0067] 1000 proliferating OPC per flask were seeded into T25 culture flasks coated with PDL followed by culturing in the TH-containing medium used in Example 1 for 15 days at 37 C. in a gas having an oxygen concentration of 1.5% by volume and carbon dioxide concentration of 5% by volume. Next, the cells were recovered from the culture flasks and three new T25 culture flasks coated with PDL were prepared by again seeding with 1000 adult OPC per flask followed by culturing for 7 days at 37 C. in a gas having an oxygen concentration of 20% by volume and carbon dioxide concentration of 5% by volume. One of the three culture flasks was cultured with the TH-free medium used in Example 1, the remaining culture flask was cultured with the medium containing IN (medium obtained by adding NRG1 (50 ng/mL) and IBMX (0.1 mM) to the TH-free medium used in Example 1).
[0068] Following completion of culturing, the numbers of cells that formed colonies were counted and the number of cell divisions was determined for each colony.
Example 6
[0069] An investigation was made of the effect of oxygen concentration on proliferating OPC by culturing proliferating OPC in medium to which was added thyroid hormone in an environment having an oxygen concentration of 1.0, 1.5, 2.0, 2.5 or 3.0% by volume.
[0070] Five T25 culture flasks coated with PDL were prepared by seeding with 1000 proliferating OPC per flask, followed by culturing for 10 days at 37 C. in the TH-containing medium used in Example 1 in a gas having an oxygen concentration of 1.0% by volume to 3.0% by volume and having a carbon dioxide concentration of 5% by volume.
[0071] Following completion of culturing, the number of viable cells in each culture flask was counted.
Example 7
[0072] An investigation was made of the proliferation ability of proliferating OPC by culturing in medium to which was added thyroid hormone in an environment having an oxygen concentration of 1.0% by volume or 3.0% by volume using proliferating OPC having purity (percentage of proliferating OPC relative to all cells) of 99.9% or more isolated from the optic nerves of 7-day-old C57BL/6 mice in accordance with the immunopanning method of Barres, et al. (Barres, et al., Cell, 1992, Vol. 70, p. 31-46).
[0073] Six glass bottom culture dishes having a diameter of 12 mm and coated with PDL were prepared by seeding with 300 mouse proliferating OPC per flask, followed by culturing three of the culture dishes in a gas having an oxygen concentration of 1.0% by volume and carbon dioxide concentration of 5% by volume, and culturing the remaining three culture dishes in a gas having an oxygen concentration 3.0% by volume and carbon dioxide concentration of 5% by volume, for 12 days at 37 C. in the TH-containing medium used in Example 1, respectively.
[0074] Following completion of culturing, the number of cells of each clone was counted and the respective numbers of cell divisions were estimated. More specifically, cells were estimated, for example, to undergo cell division three times in the case of 5 to 8 cells, and undergo cell division four times in the case of 9 to 16 cells.